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Whether the palmar skin has a role in the development, propagation or recurrence of 29 
'XSX\WUHQ¶VGLVHDVHUHPDLQVXQFOHDU&OLQLFDODVVHVVPHQWIRUVNLQ involvement is difficult 30 
and its correlation with histology uncertain. We prospectively biopsied the palmar skin of 31 
consecutive patients undergoing single digit IDVFLHFWRP\IRUSULPDU\'XSX\WUHQ¶VGLVHDVH32 
without clinically involved skin) and dermofasciectomy (for clinically involved skin or 33 
recurrence), in order to investigate this relationship. We found dermal fibromatosis in 22 of 34 
44 (50%) patients undergoing fasciectomy and 41 of 59 patients (70%) undergoing 35 
dermofasciectomy. Dermal fibromatosis appeared to be associated with greater pre-36 
operative angular deformity, the presence of palmar nodules and occupations involving 37 
manual labour. Dermal fibromatosis exists in the absence of clinical features of skin 38 
involvement and we hypothesise that the skin may have a greater role in the development 39 
DQGSURSDJDWLRQRI'XSX\WUHQ¶VGLVHDVHWKDQSUHYLRXVO\WKRXJKW 40 
 41 
Abstract word count = 1401 42 
Article word count = 29709 43 
 44 
Level of Evidence = 3 45 
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INTRODUCTION 47 
 48 
'XSX\WUHQ¶VGLVHDVHLVDFRPPRQILEURSUROLIHUDWLYHGLVRUder with a worldwide prevalence of 49 
up to 321.6% (Lanting et al., 2014). Despite its morbidity and associated costs to health 50 
services (Gerber et al., 2011) many aspects of the pathogenesis, classification and 51 
management remain strongly debated. In particular, the role of the palmar skin in the 52 
development, propagation, surgical management and risk of recurrence remains uncertain. 53 
 54 
7KHUHDUHQXPHURXVWUHDWPHQWPRGDOLWLHVDYDLODEOHIRUSDWLHQWVZLWK'XSX\WUHQ¶VGLVHDVH55 
(Eaton, 2014). Mild disease may be observed. Intralesional collagenase injections, 56 
percutaneous needle fasciotomy or selective aponeurectomy are suitable for palmar disease 57 
proximal to the metacarpophalangeal joints (MCPJs), although progression or recurrence 58 
affects up to 85% of cases (Betz et al., 2010; Mehta and Belcher, 2014; Mickelson et al., 59 
2014; van Rijssen et al., 2012; Verheyden, 2015). Limited fasciectomy (Hueston, 1961) is 60 
the most common primary procedure for moderate to severe disease, although again up to 61 
100% of patients experience recurrence or extension (Kan et al., 2013; Werker et al., 2012). 62 
,QWKHV+XHVWRQVXJJHVWHGWKDWUHFXUUHQW'XSX\WUHQ¶VGLVHDVHVKRXOGEHPDQDJHGE\63 
skin replacement (Hueston, 1962; Hueston, 1969). This hypothesis was developed by Logan 64 
and colleagues, compounding the importance of radically excising all pre-axial tissue (skin, 65 
fat and fibrous tissue) and covering the defect with a full thickness skin graft (FTSG) (Logan 66 
et al., 1985; Searle and Logan, 1992). The same group later showed that fibromatosis was 67 
SUHVHQWLQWKHVNLQRISDWLHQWVZLWKUHFXUUHQW'XSX\WUHQ¶VGLVHDVHDQGWKHUHIRUHVXJJHVWHG68 
dermofasciectomy to be the most appropriate surgical option (McCann et al., 1993). Since 69 
then, dermofasciectomy and FTSG have been shown to reduce the risk of recurrence by up 70 
to 33% (Abe et al., 2004; Armstrong et al., 2000; Brotherston et al., 1994; Ebelin et al., 1991; 71 
Hall et al., 1997; Hueston, 1984; Kelly and Varian, 1992; Ketchum and Hixson, 1987; Tonkin 72 
et al., 1984). The current clinical indications for dermofasciectomy include recurrent disease 73 
and clinically involved skin. However, clinical assessment for skin involvement is difficult and 74 
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of debatable reliability. Moreover, the relationship between clinical assessment and 75 
histological involvement is unclear. To-date, there is limited literature comparing the clinical 76 
DQGKLVWRORJLFDOIHDWXUHVRI'XSX\WUHQ¶VGLVHDVHLQWKHVNLQ(Chen et al., 2009; Hall et al., 77 
1997; Hindocha et al., 2011; Iqbal et al., 2012; Logan et al., 1985; McCann et al., 1993) and 78 
no reports on microscopic examination of clinically uninvolved skin. 79 
 80 
As the palmar skin may be LQYROYHGE\'XSX\WUHQ¶VGLVHDVHPRUHRIWHQWKDQthe clinical 81 
assessment suggests, our objective was to compare the histological characteristics of the 82 
palmar skin with clinical outcomes, for patients undergoing fasciectomy and 83 
dermofasciectomy.  84 
85 
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METHODS 86 
 87 
Between November 2009 and November 2012, an electronic database was prospectively 88 
completed in order to capture the details of all consecutive patients undergoing fasciectomy 89 
RUGHUPRIDVFLHFWRP\IRU'XSX\WUHQ¶VGLVHDVHXQGHUWKHFDUHRIWKHVHQLRUDXWKRU$)7KLV90 
database was retrospectively reviewed and supplemented by written and electronic notes.  91 
 92 
$FFRUGLQJWRRXU+RVSLWDO¶VIXQGLQJSURWRFROVXUJHU\LVRIIHUHGZKHQWKHGLVHDVHDGYHUVHO\93 
affects day-to-day activities with pain or when a digital contracture in any joint(s) is >20o. 94 
Skin involvement was defined by the presence of palmar pits, with or without firm and 95 
deficient skin tethered to a nodule or cord (Townley et al., 2006). Recurrence was defined by 96 
the return of nodules or cords in a previously operated area in association with recurrent 97 
contracture(s) >20o (Kan et al., 2013). We offer dermofasciectomy when there is obvious 98 
clinical evidence of skin involvement or in the presence of recurrent contracture(s). 99 
Otherwise, we offer a fasciectomy as the primary procedure in all cases. 100 
 101 
This study was originally designed as an audiWRIVXUJLFDORXWFRPHVRQ'XSX\WUHQ¶VGLVHDVH 102 
(Institutional registration number PS2013009). In order to minimise confounding variables 103 
and biases, we appraised only patients undergoing surgery on one digit of one hand for 104 
'XSX\WUHQ¶VGLVHDVH:HIHOWWKDW this would allow more reliable comparisons and 105 
conclusions to be drawn, ie. range of motion would not be adversely effected by surgery on 106 
adjacent digits or the palm, all the grafts would be of a similar size as only one digit was 107 
covered, etc. Therefore, at baseline we excluded patients undergoing bilateral, multi-digit or 108 
simultaneous non-'XSX\WUHQ¶VVXUJHU\HJFDUSDOWXQQHOGHFRPSUHVVLRQ$WEDVHOLQHZH109 
also excluded those who declined the offered/advised procedure and those presenting with 110 
a 2nd second recurrence within a previously operated ray (ie. requiring a 3rd third surgery to 111 
the same ray), as we felt that this would further increase the heterogeneity of the cohort. We 112 
also retrospectively excluded those patients with unavailable/unclear histological diagnoses 113 
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(Figure 1). Patients were grouped as fasciectomy or dermofasciectomy for comparative 114 
analysis. 115 
 116 
Within the study period, all consecutive patients were counselled, consented and operated 117 
on by the same author (AF). Fasciectomy involved either Bruner or Skoog incision(s), 118 
followed by careful dissection and excision of pathological tissue whilst preserving 119 
neurovascular structures. For patients undergoing fasciectomy, a sliver of skin from the 120 
margin of the incisions (mean size 3x11 mm) directly overlying a cord or nodule on the 121 
palmar aspect of the involved finger, was excised and sent for histological analysis. 122 
According to Logan and colleagues (Hall et al., 1997; McCann et al., 1993), 123 
dermofasciectomy was performed by excising the palmar skin and underlying subcutaneous 124 
tissue from the distal palmar crease up to the distal interphalangeal joint (DIPJ) crease as 125 
necessary, following mid-lateral incisions. The entire specimen was sent for histological 126 
analysis. FTSGs were harvested from the ipsilateral medial arm and inset with absorbable 4-127 
EUDLGHGVXWXUHV9LFU\OUDSLGHDQGDWLH-over dressing. The hand was wrapped in soft 128 
dressing without splintage (Jerosch-Herold et al., 2011; Kemler et al., 2012). All operations 129 
were planned as day case procedures and patients only stayed overnight for social reasons 130 
or pain relief. 131 
 132 
Data including age, sex, occupation, handedness and medical history were recorded 133 
alongside the degree of digital deformities and presence of palpable cords or nodules. We 134 
classified builders, plumbers, factory workers and similar roles as manual labourers. Angular 135 
deformities at the MCPJs, proximal interphalangeal joints (PIPJs) and DIPJs were measured 136 
with a standard office goniometer placed on the dorsum of the digit, by an independent Hand 137 
Therapist before surgery and 6 six months after surgery (Ellis and Bruton, 2002). The 138 
cumulative flexion deformity was calculated as the sum of the deformities measured at the 139 
MCPJ, PIPJ and DIPJ for the given digit. For the purpose of statistical analysis, the IPJ of 140 
the thumb was categorised as a PIPJ. Preoperative clinical assessment for skin involvement 141 
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was undertaken and recorded by the senior author during the first consultation. Tissue 142 
samples were sectioned into multiple slices for H&E stain microscopy by experienced 143 
specialised skin histopathologists. The diagnosis of dermal fibromatosis was binary and 144 
based on overall morphology. We considered a partial graft failure as necrosis of less than 145 
ten percent<10% of the graft. Complex Regional Pain Syndrome was diagnosed according 146 
to the International Association for the Study of Pain criteria (Harden et al., 2007). Follow-up 147 
ranged between 6 six and 26 twenty six months with (a mean of 12.4 months).    148 
 149 
Normally distributed data are presented as means with standard deviations (SD) and 150 
compared by the independent samples t-tests. Skewed distributions are presented as 151 
medians with interquartile ranges (IQR) and compared by the the Mann-Whitney U-Test. 152 
Categorical variables (as frequencies with percentages) were compared with Chi Square or 153 
)LVKHU¶VH[DFWWHVWVWRJHQHUDWHRGGVUDWLRV25ZLWKFRQILGHQFHLQWHUYDOV&,As we 154 
changed the focus of our study (from the planned audit of surgical outcomes to focus on the 155 
high rate of skin involvement), we performed multiple analyses; therefore, in order to 156 
address this we have generated a family wise error rate according to the Bonferroni method 157 
and our significance level is set at p<0.002. 158 
159 
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RESULTS 160 
 161 
'XULQJWKHVWXG\SHULRGVXUJLFDOSURFHGXUHVIRU'XSX\WUHQ¶VGLVHDVHZHUHSHUIRUPHG162 
Of these, 103 cases were included and the reasons for exclusion are shown in Figure 1. 163 
There were 44 fasciectomies (432.7%) and 59 dermofasciectomies (57.3%).  164 
 165 
7DEOHVKRZVSDUWLFLSDQWV¶GHPRJUDSKLFV'HUPRIDVFLHFWRP\appeared to be more 166 
common amongst participants who had previously required surgery IRU'XSX\WUHQ¶VGLVHDVH167 
on the same hand (732.8% vs. 52.3%, p=0.039). Of the dermofasciectomies, 29 were for 168 
recurrent disease (49.2%).  169 
 170 
The mean total anaesthetic time for dermofasciectomy and FTSG was significantly greater 171 
than fasciectomy (2 hours 36 minutes vs. 1 hour 49 minutes, p<0.001). Thirty-two patients 172 
(31.1%) stayed overnight. 173 
 174 
Outcomes are shown in Table 2. Histopathologically, dermal fibromatosis was present in  175 
61.2% of cases. Further, out of 44 patients with dermal involvement This included 22 176 
patients (50%) withhad no clinical features of skin involvement who and so underwent 177 
fasciectomy, as per protocol. 178 
 179 
Pre-operative angular deformity appeared to be greater in the dermofasciectomy group, 180 
although this was not statistically significant after statistical correction. Similarly, both Both 181 
groups attained a straighter finger post-operatively, although again there wereas no 182 
statistical differences between groups. Histologically proven dermal fibromatosis was not 183 
related to the post-operative range of movement. 184 
 185 
Complications were not different between groups although partial graft failure appeared to 186 
be more common amongst smokers (mean 20.0 vs. 1.25 pack years, p=0.050).  187 
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 188 
During the study period, ten patients (9.7%) underwent two operations and one required four 189 
operations. After fasciectomy, six patients (143.6%) developed early recurrence of whom 190 
four elected to undergo revision dermofasciectomy. There were no early recurrences in the 191 
dermofasciectomy group. 192 
 193 
Table 3 shows the 29 patients who underwent dermofasciectomy for recurrent disease. 194 
Clinical assessment of their skin did not correlate with the histopathological diagnosis in 9 195 
nine cases (31%). It is important to notice that when we clinically assessed the skin and felt 196 
it was involved, we were incorrect 4 four times (243.5%), giving a positive predictive value of 197 
776.5%. However, when we felt the skin was not involved clinically we were incorrect 5 five 198 
times (421.7%), giving a negative predictive value of 58.3%. In our experience, clinical 199 
assessment has a sensitivity of 72.2% and specificity of 643.6%,. 200 
 201 
Positive predictors of dermal fibromatosis included an occupation involving manual labour 202 
and the presence of palpable palmar nodules (Table 4).  203 
204 
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DISCUSSION 205 
 206 
'XSX\WUHQ¶VGLVHDVHLVK\SRWKHVLVHGWREHJLQZLWKLQWKHSDOPDUDSRQHXURVLVDQGSURJUHVV207 
axially to infiltrate fascial bands investing deep structures as well as the overlying skin. 208 
Occult fibromatosis within the dermis may be an important factor in recurrent disease (Abe et 209 
al., 2004; Armstrong et al., 2000; Brotherston et al., 1994; Ebelin et al., 1991; Hall et al., 210 
1997; Kelly and Varian, 1992; Ketchum and Hixson, 1987; Logan et al., 1985; McCann et al., 211 
1993; Searle and Logan, 1992) and therefore many surgeons have suggested that when 212 
there is evidence of skin involvement, dermofasciectomy may better treat the disease 213 
burden. For this reason, dermofasciectomy plays an important role in patients with obviously 214 
involved skin or recurrent disease (Abe et al., 2004; Armstrong et al., 2000; Brotherston et 215 
al., 1994; Ebelin et al., 1991; Hall et al., 1997; Hueston, 1984; Kelly and Varian, 1992; 216 
Ketchum and Hixson, 1987; McCann et al., 1993; Tonkin et al., 1984). Despite this general 217 
consensus, there is limited histhopathological data on the rate of dermal involvement in 218 
'XSX\WUHQ¶VGLVHDVHDQGWKHSDUDPRXQWFKDOOHQJHUHPDLQVLQWKHFOLQLFDOLGHQWLILFDWLRQRI219 
those patients with skin involvement. Consequently, it is very difficult to say who may benefit 220 
from fasciectomy or dermofasciectomy with respect to the risk of recurrence. Whilst we are 221 
QRWWKHILUVWWRVXJJHVWWKDW'XSX\WUHQ¶VGLVHDVHH[LVWVLQWKHVNLQ(Chen et al., 2009; 222 
McCann et al., 1993) and subcutaneous tissue (Hindocha et al., 2011; Iqbal et al., 2012), we 223 
have demonstrated the presence of dermal fibromatosis in patients with no clinical features 224 
of skin involvement. These findings represent a novel and interesting opportunity for further 225 
research. 226 
 227 
The most thought-provoking finding of our study is the overall rate of dermal fibromatosis 228 
(61.2%). Let us also consider that this prevalence is likely to be an underestimation of the 229 
actual percentage of dermal infiltration because only a small piece of skin was excised 230 
(mean size 3x11 mm) and the method of specimen preparation for microscopic analysis is 231 
likely to generate skip lesions. Therefore, we speculate that there is a substantially greater 232 
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(sub-clinical) rate of skin infiltration than our study suggests. Furthermore, clinical 233 
assessment for skin involvement does not seem to be entirely reliable as we found 22 234 
patients who had histologically involved skin, but underwent primary fasciectomy because 235 
the clinical assessment of their palmar skin was negative. This means that the occult skin 236 
disease was undetected and untreated, thereby raising the question should these patients 237 
have undergone primary dermofasciectomy? And if so, how can we identify these patients 238 
with sub-clinical disease in their palmar skin? Again, we cannot answer this question and 239 
can only speculate that pre-operative skin biopsy, with thorough microscopic analysis for 240 
dermal disease, may be valuable in stratifying patients for particular interventions. 241 
Additionally, skin biopsies for dermal involvement may be a useful variable in better 242 
understanding the otherwise unpredictable pattern of recurrence in this condition. 243 
 244 
Histologically differentiating 'XSX\WUHQ¶VILEURPDWRVLVfrom hypertrophic scarring is not 245 
always possible in limited/small skin biopsies. The morphological features are similar 246 
because the tissue shows increased cellularity and fibroblastic activity in both conditions. 247 
+RZHYHUK\SHUWURSKLFVFDUVXVXDOO\IHDWXUHWKLFNEXQGOHVRIFROODJHQDQGGRQRWIRUPµEXUQW248 
RXW¶ILEURWLFQRGXOHVZKLFKDUHIUHTXHQWO\VHHQLQODWHVWDJH'XSX\WUHQ¶VGLVHDVH A potential 249 
differentiating method is nuclear staining with beta-catenin, which is typically positive in 250 
fibromatosis (Varallo et al., 2003). The diagnosis therefore relies heavily on overall 251 
morphology. Conversely, one may argue that it is not necessary to distinguish between 252 
dermal fibromatosis and excess scarring because the most important task is to excise all 253 
fibrotic tissue which results in digital contracture, regardless of the cause. Indeed, our data 254 
suggests that dermal fibromatosis was not associated to the severity of pre-operative flexion 255 
contracture nor a contributory variable to the amount of angular deformity corrected through 256 
surgery. Also, we have shown that by radically excising skin, fat, fascia, aponeurosis, scar 257 
and pathological tissue through dermofasciectomy (Logan et al., 1985), we were able to 258 
obtain a substantial greater improvement in range of motion. This gain in post-operative 259 
finger motion is likely to be related to the greater original deformity and the amount of 260 
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pathological tissue removed during dermofasciectomy.  We are unable to comprehensively 261 
explain why our dermofasciectomy patients achieved a straighter digit and suggest that this 262 
is another topic to be further investigated.  263 
 264 
Our total anaesthetic time for fasciectomy was longer than expected. Root-cause analysis 265 
revealed complications including ineffective blocks requiring conversion to general 266 
anaesthesia, difficult intubations and revision blocks for post-operative analgesia, which we 267 
do not believe are relevant to our outcomes. 268 
 269 
Anecdotally, some surgeons discourage the use of dermofasciectomy due to the alleged risk 270 
of graft loss, perceived surgical complexity and longer rehabilitation. To-date no studies have 271 
demonstrated a statistically or clinically significant risk of graft loss (Brotherston et al., 1994; 272 
Hall et al., 1997; Searle and Logan, 1992; Tonkin et al., 1984) and our series supports the 273 
concept that dermofasciectomy and full thickness skin grafting for 'XSX\WUHQ¶VGLVHDVHLVD274 
safe, effective and beneficial procedure (Armstrong et al., 2000; Brotherston et al., 1994; 275 
Hall et al., 1997; Searle and Logan, 1992; Tonkin et al., 1984). Anecdotally, these patients 276 
take longer to return to their normal daily activities and this should be balanced against a 277 
potentially lower rate of recurrence and revision surgery ± a hypothesis, which certainly 278 
deserves more investigation (Rodrigues et al., 2014).  279 
 280 
6XUJHU\IRU'XSX\WUHQ¶VGLVHDVHLQFUHDVHVKDQGPRUELGLW\DQGPay subtly increase mortality 281 
too (Wilbrand et al., 2005),QWKH8.WKHDQQXDOFRVWRIWUHDWLQJ'XSX\WUHQ¶VGLVHDVH282 
exceeds £41 million (Gerber et al., 2011). In the USA, disability and treatments for 283 
'XSX\WUHQ¶VGLVHDVHDFFRXQWIRUVLJQLILFDQWORVVHVWRthe economy as well as adverse effects 284 
on health insurance (Macaulay et al., 2012). Therefore, we believe that the primary 285 
procedure aimed at treating this condition should be effective for the longest possible period, 286 
particularly for younger patients at risk of early recurrence. As we have shown that dermal 287 
disease is sub-clinically present in the majority of patients, we suggest that greater research 288 
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attention should be paid to the role of the palmar skin (specifically whether by surveying the 289 
skin through pre-operative biopsy and/or excision of clinically involved skin) we may reduce 290 
the disease burden and so, the risk of recurrence. Pre-operative skin biopsy would be 291 
particularly useful in understanding whether a heavy dermal disease burden relates to early 292 
recurrence and whilst our study is underpowered to answer this question, future researchers 293 
may wish to consider the matter. The balance between surgical morbidity, long-term 294 
outcomes, recurrence and cost is still unclear and histological detection of skin involvement 295 
may be an important piece of the puzzle. 296 
 297 
We must acknowledge two substantial limitations to our study. This was originally designed 298 
as an audit of surgical outcomes and the finding of a high rate of skin involvement generated 299 
the idea for this paper. Therefore, we performed a generous number of statistical analyses 300 
(which some may call µdata mining¶) and fully accept the inherent risk of generating type 1 301 
one errors. Consequently, we have attempted to adjust our cohort with the family wise error 302 
rate, which has rendered most our findings (albeit interesting), non-significant. Further, at 303 
baseline we excluded some patients which would have formed a potentially interesting 304 
subgroup (particularly those with multi-digit disease) and we are unable to correct this 305 
oversight. We hope that future researchers will take stock of our limitations and design 306 
studies to better investigate this fascinating and novel topic. 307 
308 
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CONCLUSIONS 309 
 310 
We have demonstrated that dermal fibromatosis exists in the absence of clinical features of 311 
VNLQLQYROYHPHQW:HKDYHDOVRVKRZQWKDWGHUPDOLQYDVLRQE\'XSX\WUHQ¶VGLVHDVHH[LVWVLQ312 
the majority of patients, in our series. Therefore, we suggest that the skin may have a 313 
greater role in both the development and propagation oI'XSX\WUHQ¶VGLVHDVHWKDQSUHYLRXVO\314 
thought. This study may be a useful basis for future research on skin involvement in 315 
'XSX\WUHQ¶VGLVHDVHLWVUROHLQWKHVWUDWLILFDWLRQRISDWLHQWVIRUVXUJHU\DQGLWVDVVRFLDWLRQ316 
with long-term outcomes and recurrence.  317 
 318 
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Figure Legends 425 
 426 
Figure 1. A flow diagram of patient attrition. 427 
 428 
 429 
 430 
 431 
Figure 2.  432 
An H&E stained section of skin overlying the proximal phalanx of the right little finger from a 433 
patient who underwent primary dermofasciectomy for clinical involved skin. Upper panel: an 434 
overview of the skin involved by fibromatosis showing destruction of the dermal adnexae and 435 
distortion of the normal dermal achitecture (low power). Middle panel: Dermal fibromatosis 436 
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reaching the mid-reticular dermis (medium power). Lower panel: A (high power) close up of 437 
WKHDFWLYHDUHDRI'XSX\WUHQ¶VGLVHDVH 438 
 439 
 440 
Figure 3.  441 
Upper row: Pre-operative photographs of a 68 year-old right-handed PDQZLWK'XSX\WUHQ¶V442 
disease in the left little finger, involving the overlying skin. The PIPJ demonstrated 57 443 
degrees of fixed flexion deformity. Lower row: Photographs one1- year post primary 444 
dermofasciectomy and full thickness skin grafting, showing a well-healed graft and corrected 445 
deformity. 446 
447 
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Tables 448 
 449 
Table 1. Baseline Characteristics  Fasciectomy (N=44) 
Dermofasciectomy 
& FTSG (N=59) p-value 
Mean age (SD) 65.1 (9.03) 66.2 (8.10) 0.509 
Gender (%) 
Men 34 (33.0) 51 (5049.5) 
0.226 
Women 10 (9.7) 8 (7.8) 
Handedness (%) 
Right 36 (35.0) 58 (56.3) 
0.004 
Left 8 (7.7) 1 (1.0) 
Manual Worker (%) 16 (165.5) 17 (176.5) 0.371 
Family History (%) 22 (21.4) 21 (20.4) 0.142 
Cords (%) 38 (376.9) 54 (52.4) 1.000 
Nodules (%) 20 (19.4) 22 (21.4) 0.351 
Skin clinically involved (%) / 17 (176.5) / 
 450 
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 452 
Table 2. Outcomes Fasciectomy (N=44) 
Dermofasciectomy 
& FTSG (N=59) p-value 
Skin histologically involved (%) 22 (50.0) 41 (7069.5) 0.041 
Median pre-
operative flexion 
contractures in 
degrees (IQR) 
    MCPJs 25 (20-37) 39 (30-51) 0.015 
              PIPJs 49 (26-64) 70 (56-90) 0.003 
              DIPJs 1 (0-2) 30 (5-54) 0.190 
Median post-
operative flexion 
contractures in 
degrees (IQR) 
    MCPJs 0 (0-5) 0 (0-10) 0.413 
              PIPJs 8 (0-20) 19 (0-33) 0.493 
              DIPJs 0 (0-14) 0 (0-0) 1.000 
Complications (%) 
    Infection 2 (4.54) 0 (0) 0.180 
              CRPS 1 (2.327) 1 (1.769) 1.000 
Recurrence 3 (6.82) 2 (3.439) 0.649 
  Total graft 
failure / 0 (0) / 
Partial graft 
failure / 9 (15.3) / 
Median follow-up in weeks (Range) 39 (16-72) 51 (24-96) 0.117 
 453 
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 456 
Table 3. Dermofasciectomy 
for Recurrent Contracture 
Histological Assessment of the Skin 
Involved Not Involved  p-value 
Clinical 
Assessment 
of the Skin 
(%) 
Involved 13 (454.8) 4 (1314.8) 
0.119 
Not involved 5 (17.2) 7 (24.2) 
 457 
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 459 
 Table 4. Positive Predictors of Skin Involvement 
Risk Factor  OR p-value 95% CI 
Manual Worker 2.86 0.017 1.19, 6.86 
Palmar Nodules 4.63 0.001 1.80, 11.9 
 460 
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